Polyneuron Pharmaceuticals
Armance Bordes is Sofinnova Partners’ general councel, she has 15 years’ experience handling legal and regulatory issues in private equity and venture capital. Prior to joining Sofinnova, Armance was deputy general counsel and secretary of the board of directors at Eurazeo. Armance started her career as an M&A lawyer at Gibson Dunn & Crutcher LLP in Paris. She graduated from the University of Paris 1 Panthéon-Sorbonne and holds a postgraduate diploma from Oxford University. She is a member of the Paris bar and represents venture capital at Invest Europe's Public Affairs Executive.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Polyneuron Pharmaceuticals
2 followers
Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-Catch™ technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs.